Literature DB >> 22964931

Anthropometric and dietary intake indicators as predictors of pulmonary function in cystic fibrosis patients.

Gabriele Carra Forte1, Juliane Silva Pereira, Michele Drehmer, Miriam Isabel Souza dos Santos Simon.   

Abstract

OBJECTIVE: To evaluate whether anthropometric and dietary intake indicators are predictors of pulmonary function in cystic fibrosis (CF) patients.
METHODS: This was a cross-sectional study involving 69 patients (age range, 5.4-16.5 years) diagnosed with CF under follow-up at the Hospital de Clínicas de Porto Alegre, located in the city of Porto Alegre, Brazil. Anthropometric assessment was based on body mass index (BMI), mid-arm muscle circumference (MAMC), and triceps skinfold thickness (TST). Dietary intake was assessed by using recall data, which were compared with the recommended dietary allowances. Pulmonary function was assessed by ventilatory capacity, expressed as FEV(1). Prevalence ratios for the outcome studied (FEV(1) < 80% of predicted) were calculated by indicator.
RESULTS: In patients with MAMC and TST below the 25th percentile, the prevalence of FEV(1) < 80% of predicted was significantly higher than in those with higher MAMC and TST (p < 0.001 and p = 0.011, respectively). In comparison with other patients, those with a BMI below the 50th percentile showed a 4.43 times higher prevalence of FEV(1) < 80% of predicted (95% CI: 1.58-12.41), and that prevalence was 2.54 times higher in those colonized with methicillin-resistant Staphylococcus aureus (MRSA) than in those not so colonized (95% CI: 1.43-4.53). The association between dietary intake and the prevalence of FEV1 < 80% of predicted was of only borderline significance (95% CI: 0.95-3.45).
CONCLUSIONS: Not being colonized with MRSA and having a BMI above the 50th percentile appear to preserve pulmonary function in CF patients.

Entities:  

Mesh:

Year:  2012        PMID: 22964931     DOI: 10.1590/s1806-37132012000400009

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  3 in total

1.  Cystic fibrosis patients at risk for disease progression marked by decline in FEV1% predicted: development of the cystic fibrosis risk of disease progression score.

Authors:  Nathan L Marsteller; Eliezer Nussbaum; Tricia Morphew; Inderpal S Randhawa
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

Review 3.  What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?

Authors:  Josie M van Dorst; Rachel Y Tam; Chee Y Ooi
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.